Sattva Sukun board meets May 30 to consider Q4FY26 results
Sattva Sukun Lifecare Limited will hold a board meeting on May 30, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The agenda includes reviewing the audit report and rights issue proceeds. The trading window is closed until 48 hours post-meeting.

*this image is generated using AI for illustrative purposes only.
Sattva Sukun Lifecare Limited has scheduled a meeting of its Board of Directors on Saturday, May 30, 2026. The meeting will be held at the company's registered office in Mumbai to discuss and approve key financial and regulatory matters.
The primary agenda item is the consideration and approval of the audited financial results for the quarter and year ended March 31, 2026. The board will review both standalone and consolidated figures pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Alongside the results, the directors will also approve the audit report.
Key Agenda Items
The board meeting will cover several critical topics:
- Approval of Audited Financial Results (Standalone & Consolidated) for Q4 and FY26.
- Approval of the Audit Report on the financial results.
- Discussion on the use of proceeds from the rights issue offer document and submission of deviation statements.
- Declaration regarding the Auditors' Report with unmodified opinions.
Trading Window Closure
In compliance with the Company's Code of Conduct on Insider Trading and SEBI regulations, the trading window for designated persons and their immediate relatives remains closed. The window closed on April 01, 2026, and will remain shut until 48 hours after the conclusion of the board meeting for the approval of the audited financial results.
The meeting will also address any other business with the permission of the Chairman.
Historical Stock Returns for Sattva Sukun Lifecare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.67% | +2.67% | +8.45% | +13.24% | -28.70% | -59.69% |
How did Sattva Sukun Lifecare's FY26 revenue and profitability metrics compare to its FY25 performance, and what growth trajectory can investors expect going forward?
What were the specific proceeds from the rights issue utilized for, and did the actual deployment align with the originally stated objectives in the offer document?
Following the board meeting, will the company announce any dividend declaration or capital allocation strategy for FY27 given its current financial position?
































